Methoxybenzoic acids and derivatives
Medchemexpress LLC 2-Hydroxy-4-methoxyb 100g
2-Hydroxy-4-methoxybenzoic acid (potassium) is one of the major phytoconstituents of Decalepis arayalpathra also known as 4-Methoxysalicylic acid (potassium) has a variety of biological effects including anti-inflammatory antipyretic antioxidant and anti-diabetic properties[1]
Medchemexpress LLC p-Anisic acid | 100-09-4 | 152.15 | 5 G
p-Anisic acid (4-Methoxybenzoic acid) is an orally available tyrosinase inhibitor with antioxidant, anti-anxiety, anti-inflammatory, anti-tumor, anti-diabetic, and preservative properties. It can be utilized as a preservative in the cosmetics field.
- Orally available tyrosinase inhibitor
- Possesses antioxidant properties
- Exhibits anti-anxiety effects
- Anti-inflammatory activity
- Demonstrates anti-tumor properties
- Has anti-diabetic effects
- Acts as a preservative for cosmetics
- Stable under recommended storage conditions
- Can be stored at room temperature for 3 years, or in solvent at -80°C for 2 years, -20°C for 1 year
![eMolecules 871830-02-3 | [4-(Cyclopentyloxy)phenyl]boronic acid | MFCD08461671 | 1g](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502138921.JPG-250.jpg)
eMolecules 871830-02-3 | [4-(Cyclopentyloxy)phenyl]boronic acid | MFCD08461671 | 1g
Ambeed | [4-(Cyclopentyloxy)phenyl]boronic acid | 1g | 600827666 | A1135077 | 871830-02-3 | MFCD08461671 | 206.050 | C11H15BO3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC Ro 08-2750 | 37854-59-4 | 98.01% | 270.24 | 10 MG
Ro 08-2750 is a non-peptide and reversible nerve growth factor (NGF) inhibitor that binds to NGF with an IC50 of approximately 1 μM. It selectively inhibits NGF binding to p75NTR over TRKA. Ro 08-2750 is also a selective MSI RNA-binding activity inhibitor, with an IC50 of 2.7 μM.
- Binds to the NGF dimer, potentially inducing a conformational change that prevents NGF from binding to p75NTR.
- Completely rescues cells from NGF-induced SK-N-MC 103 cell death at 10 nM.
- Increases differentiation and apoptosis in myeloid leukemia cells at 5-10 μM (8 hours).
- Inhibits survival of human AML lines and patient cells.
- Inhibits MSI2 RNA-binding and alters MSI2 gene signature.
- Inhibits leukemogenesis in a myeloid leukemia model in vivo at 13.75 mg/kg (i.p.).
- Reduces c-MYC levels and disease burden in a myeloid leukemia model.